Maha's Covid-19 curve not flattening despite drop in numbers, cautions Tope

Vaccination and restrictions are key to arrest the spread of the infection, he stressed

Rajesh Tope
Rajesh Tope | Photo: ANI
Press Trust of India Mumbai
2 min read Last Updated : Jan 12 2022 | 9:58 PM IST

Maharashtra Health minister Rajesh Tope on Wednesday cautioned that the coronavirus curve in the state is not flattening despite a dip in the number of daily COVID-19 cases in the last couple of days.

He said there is a silver lining that out of the 2.25 lakh active cases, only 14 per cent are under hospitalisation.

Tope said he doesn't expect the situation to stablise by January end or by early February, and urged those who have not undergone vaccination to take jabs, besides masking-up by all.

Vaccination and restrictions are key to arrest the spread of the infection, he stressed.

Tope also pointed out that the vaccination rate needs to be ramped up.

He said he has asked for 50 lakh doses of Covisheild and 40 lakh does of Covaxin during a meeting with Union Health Minister Mansukh Mandaviya.

"The cases have seen a decline in the last two days, but this does not mean that the curve is flattening. There are 46,000 cases today. So there is no flattening of the curve," Tope told reporters.

The positivity rate of the state stands at 21.04 per cent and Mumbai's positivity rate is 27 per cent, he said, adding that of the 2.25 lakh active cases, only 0.32 per cent - less than a per cent - require ventilator.

On the supply of medical oxygen, he said the current demand is around 400 metric tonnes. Of this, 250 tonnes is for non-COVID patients and the rest for coronavirus patients.

He said that if the oxygen demand exceeds 800 metric tonnes, then lockdown will be imposed in the state.

On legendary singer Lata Mangeshkar, who has been admitted at the Breach Candy Hospital after testing positive for coronavirus, Tope said the doctors have been instructed to share the real time information on the Bharat Ratna recipient's health.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusMaharashtaCoronavirus Vaccine

First Published: Jan 12 2022 | 9:58 PM IST

Next Story